XOMA Plans Public Offering Of 9M Shares Following Panel Nod Sep. 12, 2003 By Aaron Lorenzo Two days after an FDA advisory panel recommended approval of its partnered psoriasis drug Raptiva, XOMA Ltd. disclosed plans for a public offering of 9 million common shares. (BioWorld Today)Read More
